Clinical targets of A2B adenosine receptor antagonists

被引：0
|
作者：
Linden, J
Figler, RA
Jacobson, KA
Wang, GQ
LaNoue, KF
机构：
[1] Univ Virginia, Sch Med, Dept Mol Physiol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Med, Dept Biol Phys, Charlottesville, VA 22908 USA
[3] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA
[4] Adenosine Therapeut LLC, Charlottesville, VA USA
[5] NIH, Bethesda, MD 20892 USA
[6] Penn State Univ, Hershey, PA USA
来源：
DRUG DEVELOPMENT RESEARCH | 2002年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
51
引用
收藏
页码：556 / 556
页数：1
相关论文
共 50 条
  • [1] Prodrugs of A2B adenosine receptor antagonists
    Kalla, Rao
    Elzein, Elfatih
    Koltun, Dmitry
    Li, Xiaofen
    Perry, Thao
    Parkhill, Eric
    Zeng, Dewan
    Fong, Irving
    Leung, Kwan
    Zablocki, Jeff
    PURINERGIC SIGNALLING, 2008, 4 : S21 - S22
  • [2] Irreversible Antagonists for the Adenosine A2B Receptor
    Temirak, Ahmed
    Schlegel, Jonathan G.
    Voss, Jan H.
    Vaassen, Victoria J.
    Vielmuth, Christin
    Claff, Tobias
    Mueller, Christa E.
    MOLECULES, 2022, 27 (12):
  • [3] A2B adenosine receptor antagonists and their potential indications
    Zablocki, Jeff
    Elzein, Elfatih
    Kalla, Rao
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (10) : 1347 - 1357
  • [4] A2B Adenosine Receptor Antagonists with Picomolar Potency
    Jiang, Jie
    Seel, Catharina Julia
    Temirak, Ahmed
    Namasivayam, Vigneshwaran
    Arridu, Antonella
    Schabikowski, Jakub
    Baqi, Younis
    Hinz, Sonja
    Hockemeyer, Joerg
    Mueller, Christa E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (08) : 4032 - 4055
  • [5] A2B adenosine receptor antagonists:: Recent developments
    Cacciari, B
    Pastorin, G
    Bolcato, C
    Spalluto, G
    Bacilieri, M
    Moro, S
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (12) : 1053 - 1060
  • [6] A2B adenosine receptor antagonists for asthma and diabetes.
    Linden, J
    Figler, RA
    Wang, GQ
    Jones, DR
    Jacobson, KA
    LaNoue, KF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U79 - U79
  • [7] Discovery of new antagonists of the adenosine A2B receptor.
    Webb, TR
    Lvovskiy, D
    Melman, N
    Ji, X
    Linden, J
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U6 - U6
  • [8] Antinociceptive effects of novel A2B adenosine receptor antagonists
    Abo-Salem, OM
    Hayallah, AM
    Bilkei-Gorzo, A
    Filipek, B
    Zimmer, A
    Müller, CE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (01): : 358 - 366
  • [9] Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates
    Kalla, Rao V.
    Zablocki, Jeff
    PURINERGIC SIGNALLING, 2009, 5 (01) : 21 - 29
  • [10] Quinazolines as adenosine receptor antagonists:: SAR and selectivity for A2B receptors
    Webb, TR
    Lvovskiy, D
    Kim, SA
    Ji, XD
    Melman, N
    Linden, J
    Jacobson, KA
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (01) : 77 - 85
12345